Product
YPEG-rhGH
1 clinical trial
3 indications
Indication
Idiopathic Short StatureIndication
Small for Gestational AgeIndication
Turner syndromeClinical trial
A Multicenter, Randomized, Open-label, Positive-controlled Phase 2 Study to Explore the Optimal Dose of Y- Shaped Pegylated Recombinant Growth Hormone (YPEG-rhGH) in Children With Short Stature (ISS, SGA, TS)Status: Completed, Estimated PCD: 2023-10-23